{"id":364717,"date":"2025-08-31T12:50:20","date_gmt":"2025-08-31T12:50:20","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-kymera-therapeutics\/"},"modified":"2025-08-31T12:50:20","modified_gmt":"2025-08-31T12:50:20","slug":"how-to-buy-kymera-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334009,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-364717","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Kymera Therapeutics, Inc. (KYMR) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu KYMR","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Kymera Therapeutics, Inc. (KYMR) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu KYMR"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Kymera Therapeutics (KYMR) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, c\u00e1c ch\u1ea5t x\u00fac t\u00e1c t\u0103ng tr\u01b0\u1edfng n\u0103m 2025 v\u00e0 h\u01b0\u1edbng d\u1eabn mua t\u1eebng b\u01b0\u1edbc cho c\u01a1 h\u1ed9i trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Kymera Therapeutics (KYMR) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, c\u00e1c ch\u1ea5t x\u00fac t\u00e1c t\u0103ng tr\u01b0\u1edfng n\u0103m 2025 v\u00e0 h\u01b0\u1edbng d\u1eabn mua t\u1eebng b\u01b0\u1edbc cho c\u01a1 h\u1ed9i trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc."},"intro":"B\u1ea1n mu\u1ed1n s\u1edf h\u1eefu m\u1ed9t ph\u1ea7n c\u1ee7a cu\u1ed9c c\u00e1ch m\u1ea1ng c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u1ebfp theo? Kymera Therapeutics (KYMR) \u0111ang ti\u00ean phong c\u00f4ng ngh\u1ec7 ph\u00e2n h\u1ee7y protein c\u00f3 m\u1ee5c ti\u00eau c\u00f3 th\u1ec3 thay \u0111\u1ed5i c\u00e1ch ch\u00fang ta \u0111i\u1ec1u tr\u1ecb b\u1ec7nh. \u0110\u00e2y kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u1ed5 phi\u1ebfu d\u01b0\u1ee3c ph\u1ea9m th\u00f4ng th\u01b0\u1eddng\u2014m\u00e0 l\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 v\u00e0o khoa h\u1ecdc ti\u00ean ti\u1ebfn v\u1edbi ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng l\u1edbn. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao KYMR x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c ch\u00fa \u00fd v\u00e0 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 tham gia h\u00e0nh tr\u00ecnh th\u00fa v\u1ecb n\u00e0y.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n mu\u1ed1n s\u1edf h\u1eefu m\u1ed9t ph\u1ea7n c\u1ee7a cu\u1ed9c c\u00e1ch m\u1ea1ng c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u1ebfp theo? Kymera Therapeutics (KYMR) \u0111ang ti\u00ean phong c\u00f4ng ngh\u1ec7 ph\u00e2n h\u1ee7y protein c\u00f3 m\u1ee5c ti\u00eau c\u00f3 th\u1ec3 thay \u0111\u1ed5i c\u00e1ch ch\u00fang ta \u0111i\u1ec1u tr\u1ecb b\u1ec7nh. \u0110\u00e2y kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u1ed5 phi\u1ebfu d\u01b0\u1ee3c ph\u1ea9m th\u00f4ng th\u01b0\u1eddng\u2014m\u00e0 l\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 v\u00e0o khoa h\u1ecdc ti\u00ean ti\u1ebfn v\u1edbi ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng l\u1edbn. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao KYMR x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c ch\u00fa \u00fd v\u00e0 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 tham gia h\u00e0nh tr\u00ecnh th\u00fa v\u1ecb n\u00e0y."},"body_html":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Kymera: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 31 th\u00e1ng 8 n\u0103m 2025, Kymera Therapeutics (KYMR) giao d\u1ecbch \u1edf m\u1ee9c <strong>41,20 USD<\/strong> tr\u00ean NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>30 th\u00e1ng 10 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng\u2014\u0111\u00f3 l\u00e0 khi Kymera c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3. Theo l\u1ecbch s\u1eed, c\u00e1c b\u00e1o c\u00e1o n\u00e0y th\u01b0\u1eddng l\u00e0m gi\u00e1 c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh trong ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p> <h3><strong>C\u00e1ch B\u00e1o C\u00e1o L\u1ee3i Nhu\u1eadn \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu KYMR<\/strong><\/h3> <table> <thead> <tr><th>Ng\u00e0y<\/th><th>S\u1ef1 ki\u1ec7n<\/th><th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th><th>Thay \u0110\u1ed5i Sau Tin<\/th><\/tr> <\/thead> <tbody> <tr><td>11 th\u00e1ng 8, 2025<\/td><td>L\u1ee3i nhu\u1eadn qu\u00fd 2<\/td><td>42,50 USD<\/td><td>-3,1% (kh\u00f4ng \u0111\u1ea1t \u01b0\u1edbc t\u00ednh)<\/td><\/tr> <tr><td>9 th\u00e1ng 5, 2025<\/td><td>K\u1ebft qu\u1ea3 qu\u00fd 1<\/td><td>38,20 USD<\/td><td>+8,2% (ti\u1ebfn tri\u1ec3n pipeline)<\/td><\/tr> <tr><td>Th\u00e1ng 2 n\u0103m 2025<\/td><td>B\u00e1o c\u00e1o h\u00e0ng n\u0103m<\/td><td>35,80 USD<\/td><td>+12,3% (tin \u0111\u1ed1i t\u00e1c)<\/td><\/tr> <tr><td>Th\u00e1ng 11 n\u0103m 2024<\/td><td>C\u1eadp nh\u1eadt l\u00e2m s\u00e0ng<\/td><td>32,10 USD<\/td><td>+15,8% (d\u1eef li\u1ec7u t\u00edch c\u1ef1c)<\/td><\/tr> <tr><td>Th\u00e1ng 8 n\u0103m 2024<\/td><td>Qu\u00fd 2 n\u0103m 2024<\/td><td>29,50 USD<\/td><td>-6,2% (tr\u00ec ho\u00e3n quy \u0111\u1ecbnh)<\/td><\/tr> <tr><td>Th\u00e1ng 5 n\u0103m 2024<\/td><td>Ch\u1ec9 \u0111\u1ecbnh FDA<\/td><td>26,80 USD<\/td><td>+45,6% (ph\u00ea duy\u1ec7t nhanh)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Nh\u1eadn \u0111\u1ecbnh xu h\u01b0\u1edbng<\/strong>: D\u1eef li\u1ec7u l\u00e2m s\u00e0ng t\u00edch c\u1ef1c v\u00e0 c\u00e1c c\u1ed9t m\u1ed1c quy \u0111\u1ecbnh th\u01b0\u1eddng th\u00fac \u0111\u1ea9y t\u0103ng gi\u00e1 15-45%, trong khi vi\u1ec7c kh\u00f4ng \u0111\u1ea1t l\u1ee3i nhu\u1eadn g\u00e2y ra gi\u1ea3m t\u1ea1m th\u1eddi 3-6% nh\u01b0ng th\u01b0\u1eddng nhanh ch\u00f3ng h\u1ed3i ph\u1ee5c nh\u1edd tin pipeline.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u0103ng Gi\u1ea3m C\u00f3 M\u1ee5c \u0110\u00edch<\/h2> <p>C\u1ed5 phi\u1ebfu Kymera \u0111\u00e3 mang l\u1ea1i <strong>l\u1ee3i nhu\u1eadn 7,5%<\/strong> trong 6 th\u00e1ng qua, nh\u01b0ng h\u00e0nh tr\u00ecnh kh\u00f4ng h\u1ec1 su\u00f4n s\u1ebb:<\/p> <ul> <li><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: 35,80 USD (giai \u0111o\u1ea1n c\u1ee7ng c\u1ed1 sau k\u1ef3 ngh\u1ec9)<\/li> <li><strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: 42,60 USD (tin \u0111\u1ed3n h\u1ee3p t\u00e1c v\u1edbi Gilead)<\/li> <li><strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: 38,20 USD (giai \u0111o\u1ea1n ch\u1ed1t l\u1eddi)<\/li> <li><strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: 41,30 USD (l\u1ee3i nhu\u1eadn qu\u00fd 1 v\u01b0\u1ee3t k\u1ef3 v\u1ecdng)<\/li> <li><strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: 47,80 USD (x\u00e1c nh\u1eadn th\u1ecfa thu\u1eadn Gilead +750 tri\u1ec7u USD)<\/li> <li><strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: 44,20 USD (bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng)<\/li> <li><strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: 41,20 USD (kh\u00f4ng \u0111\u1ea1t l\u1ee3i nhu\u1eadn qu\u00fd 2)<\/li> <\/ul> <p>T\u1ea1i sao l\u1ea1i bi\u1ebfn \u0111\u1ed9ng? C\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ph\u1ee5 thu\u1ed9c r\u1ea5t nhi\u1ec1u v\u00e0o k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 tin t\u1ee9c h\u1ee3p t\u00e1c. <strong>Ph\u1ea1m vi 52 tu\u1ea7n t\u1eeb 19,45 USD \u0111\u1ebfn 53,27 USD<\/strong> cho th\u1ea5y m\u1ee9c \u0111\u1ed9 b\u00f9ng n\u1ed5 c\u1ee7a c\u1ed5 phi\u1ebfu n\u00e0y (<a href=\"https:\/\/www.macrotrends.net\/stocks\/charts\/KYMR\/kymera-therapeutics\/stock-price-history\">MacroTrends<\/a>).<\/p> <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Qu\u1ef9 \u0110\u1ea1o T\u0103ng Tr\u01b0\u1edfng 2025-2030<\/h2> <ul> <li><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 52-58 USD (\u0111\u1ed9ng l\u1ef1c t\u1eeb qu\u00fd 3\/qu\u00fd 4) \u2192 <strong>MUA M\u1ea0NH<\/strong><\/li> <li><strong>D\u1ef1 b\u00e1o 2026<\/strong>: 65-75 USD (\u0111\u1ea1t c\u00e1c c\u1ed9t m\u1ed1c l\u00e2m s\u00e0ng)<\/li> <li><strong>Tri\u1ec3n v\u1ecdng 2028<\/strong>: 85-100 USD (ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i \u0111\u1ea7u ti\u00ean)<\/li> <li><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: 120-150 USD (v\u1ecb tr\u00ed d\u1eabn \u0111\u1ea7u th\u1ecb tr\u01b0\u1eddng)<\/li> <\/ul> <p><strong>K\u1ebft lu\u1eadn<\/strong>: \u0110\u00e2y l\u00e0 c\u1ed5 phi\u1ebfu <strong>t\u0103ng tr\u01b0\u1edfng d\u00e0i h\u1ea1n<\/strong> v\u1edbi ti\u1ec1m n\u0103ng nh\u00e2n 3-4 l\u1ea7n trong 5 n\u0103m. Nh\u00e0 \u0111\u1ea7u t\u01b0 ng\u1eafn h\u1ea1n n\u00ean ch\u00fa \u00fd k\u1ef9 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn ng\u00e0y 30 th\u00e1ng 10.<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i ro c\u1ea7n c\u00e2n nh\u1eafc<\/h3> <ul> <li><strong>Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: B\u1ea5t k\u1ef3 tr\u1edf ng\u1ea1i n\u00e0o trong ch\u01b0\u01a1ng tr\u00ecnh KT-621 ho\u1eb7c KT-579 c\u00f3 th\u1ec3 khi\u1ebfn c\u1ed5 phi\u1ebfu gi\u1ea3m 30-50%<\/li> <li><strong>R\u00e0o c\u1ea3n quy \u0111\u1ecbnh<\/strong>: Thay \u0111\u1ed5i t\u1eeb FDA\/EMA c\u00f3 th\u1ec3 tr\u00ec ho\u00e3n ph\u00ea duy\u1ec7t v\u00e0 t\u0103ng chi ph\u00ed<\/li> <li><strong>Ti\u00eau ti\u1ec1n m\u1eb7t<\/strong>: Chi ti\u00eau R&D qu\u00fd 78,4 tri\u1ec7u USD \u0111\u00f2i h\u1ecfi ngu\u1ed3n t\u00e0i tr\u1ee3 li\u00ean t\u1ee5c (<a href=\"https:\/\/www.ainvest.com\/news\/kymera-therapeutics-q2-2025-earnings-test-resilience-tpd-space-2508\/\">AInvest<\/a>)<\/li> <li><strong>C\u1ea1nh tranh<\/strong>: C\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn gia nh\u1eadp l\u0129nh v\u1ef1c TPD c\u00f3 th\u1ec3 g\u00e2y \u00e1p l\u1ef1c l\u00ean bi\u00ean l\u1ee3i nhu\u1eadn<\/li> <\/ul> <h3>T\u00edn hi\u1ec7u t\u00edch c\u1ef1c cho n\u0103m 2025<\/h3> <ul> <li><strong>Th\u1ecfa thu\u1eadn 750 tri\u1ec7u USD v\u1edbi Gilead<\/strong>: L\u00ean \u0111\u1ebfn 85 tri\u1ec7u USD tr\u1ea3 tr\u01b0\u1edbc k\u00e8m ti\u1ec1n b\u1ea3n quy\u1ec1n theo t\u1ea7ng (<a href=\"https:\/\/www.gilead.com\/news\/news-details\/2025\/gilead-sciences-and-kymera-therapeutics-enter-into-exclusive-option-and-license-agreement-to-develop-novel-oral-molecular-glue-cdk2-degraders\">Gilead Sciences<\/a>)<\/li> <li><strong>Ch\u1ec9 \u0111\u1ecbnh fast-track c\u1ee7a FDA<\/strong>: Ti\u1ec1n l\u1ec7 t\u0103ng gi\u00e1 c\u1ed5 phi\u1ebfu 45,58% (<a href=\"https:\/\/www.timothysykes.com\/news\/kymera-therapeutics-inc-kymr-news-2025_06_02\/\">Timothy Sykes<\/a>)<\/li> <li><strong>Qu\u1ef9 ti\u1ec1n m\u1eb7t 1 t\u1ef7 USD<\/strong>: \u0110\u1ea3m b\u1ea3o t\u00e0i tr\u1ee3 \u0111\u1ebfn n\u0103m 2028<\/li> <li><strong>20 nh\u00e0 ph\u00e2n t\u00edch \u0111\u00e1nh gi\u00e1 \"Mua\"<\/strong>: Ni\u1ec1m tin chuy\u00ean nghi\u1ec7p \u0111\u1ed3ng thu\u1eadn<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Ch\u1ec9 ph\u00e2n b\u1ed5 2-5% danh m\u1ee5c cho c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li> <li><strong>Trung b\u00ecnh gi\u00e1 theo th\u1eddi gian<\/strong>: Mua 100-200 USD m\u1ed7i tu\u1ea7n \u0111\u1ec3 tr\u00e1nh sai l\u1ea7m v\u1ec1 th\u1eddi \u0111i\u1ec3m<\/li> <li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/strong>: Mua khi gi\u00e1 gi\u1ea3m d\u01b0\u1edbi 40 USD, ch\u1ed1t l\u1eddi tr\u00ean 50 USD<\/li> <li><strong>\u0110a d\u1ea1ng h\u00f3a<\/strong>: C\u00e2n b\u1eb1ng v\u1edbi c\u1ed5 phi\u1ebfu tr\u1ea3 c\u1ed5 t\u1ee9c \u1ed5n \u0111\u1ecbnh<\/li> <li><strong>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc<\/strong>: \"Giao d\u1ecbch KYMR gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba\u2014\u0111\u1ea7y nh\u1eefng \u0111\u1ed9t ph\u00e1 th\u00fa v\u1ecb k\u00e8m theo v\u00e0i v\u1ee5 n\u1ed5 ph\u00f2ng th\u00ed nghi\u1ec7m. H\u00e3y lu\u00f4n \u0111eo k\u00ednh b\u1ea3o h\u1ed9!\"<\/li> <\/ol> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Kymera Therapeutics (KYMR) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o truy c\u1eadp NASDAQ v\u00e0 ph\u00ed th\u1ea5p<\/td><\/tr> <tr><td>2<\/td><td>M\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi 500-1000 USD \u0111\u1ec3 \u0111\u1ecbnh k\u00edch th\u01b0\u1edbc v\u1ecb th\u1ebf<\/td><\/tr> <tr><td>3<\/td><td>T\u00ecm ki\u1ebfm \"KYMR\"<\/td><td>D\u00f9ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng d\u00f9ng t\u00ean c\u00f4ng ty<\/td><\/tr> <tr><td>4<\/td><td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td><td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o<\/td><\/tr> <tr><td>5<\/td><td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td><td>Ki\u1ec3m tra t\u1ef7 l\u1ec7 hoa h\u1ed3ng (d\u01b0\u1edbi 1% l\u00e0 l\u00fd t\u01b0\u1edfng)<\/td><\/tr> <tr><td>6<\/td><td>Gi\u00e1m s\u00e1t v\u1ecb th\u1ebf<\/td><td>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7 \u1edf m\u1ee9c 15-20% d\u01b0\u1edbi gi\u00e1 v\u00e0o<\/td><\/tr> <tr><td>7<\/td><td>T\u00e1i \u0111\u1ea7u t\u01b0 c\u1ed5 t\u1ee9c<\/td><td>KYMR ch\u01b0a tr\u1ea3 c\u1ed5 t\u1ee9c\u2014t\u1eadp trung v\u00e0o t\u0103ng tr\u01b0\u1edfng<\/td><\/tr> <tr><td>8<\/td><td>Theo d\u00f5i tin t\u1ee9c<\/td><td>\u0110\u0103ng k\u00fd nh\u1eadn c\u1ea3nh b\u00e1o tin t\u1ee9c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/td><\/tr> <tr><td>9<\/td><td>\u0110\u00e1nh gi\u00e1 h\u00e0ng qu\u00fd<\/td><td>\u0110\u00e1nh gi\u00e1 l\u1ea1i sau m\u1ed7i b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn<\/td><\/tr> <tr><td>10<\/td><td>Xem x\u00e9t t\u00e1c \u0111\u1ed9ng thu\u1ebf<\/td><td>Gi\u1eef tr\u00ean 1 n\u0103m \u0111\u1ec3 \u0111\u01b0\u1ee3c \u01b0u \u0111\u00e3i thu\u1ebf l\u1ee3i t\u1ee9c v\u1ed1n<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>Pocket Option gi\u00fap \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc tr\u1edf n\u00ean d\u1ec5 ti\u1ebfp c\u1eadn cho m\u1ecdi ng\u01b0\u1eddi:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u: 5 USD<\/strong> \u2014 Th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro th\u1ea5p<\/li> <li><strong>X\u00e1c minh trong 1 ph\u00fat<\/strong> \u2014 KYC ch\u1ec9 v\u1edbi m\u1ed9t t\u00e0i li\u1ec7u gi\u00fap b\u1ea1n giao d\u1ecbch ngay l\u1eadp t\u1ee9c<\/li> <li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> \u2014 Bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed, chuy\u1ec3n kho\u1ea3n ng\u00e2n h\u00e0ng<\/li> <li><strong>C\u1ed5 phi\u1ebfu ph\u00e2n \u0111o\u1ea1n<\/strong> \u2014 Mua c\u1ed5 phi\u1ebfu m\u1ed9t ph\u1ea7n c\u1ee7a c\u00e1c c\u1ed5 phi\u1ebfu \u0111\u1eaft ti\u1ec1n nh\u01b0 KYMR<\/li> <\/ul> <h2>\ud83c\udf0d Kymera N\u0103m 2025: Ng\u01b0\u1eddi Ti\u00ean Phong Ph\u00e2n H\u1ee7y Protein<\/h2> <p>Kymera Therapeutics kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u00f4ng th\u01b0\u1eddng\u2014h\u1ecd \u0111ang d\u1eabn \u0111\u1ea7u cu\u1ed9c c\u00e1ch m\u1ea1ng ph\u00e2n h\u1ee7y protein c\u00f3 m\u1ee5c ti\u00eau. C\u00f4ng ngh\u1ec7 c\u1ee7a c\u00f4ng ty s\u1eed d\u1ee5ng \"keo ph\u00e2n t\u1eed\" \u0111\u1ec3 lo\u1ea1i b\u1ecf c\u00e1c protein g\u00e2y b\u1ec7nh thay v\u00ec ch\u1ec9 ch\u1eb7n ch\u00fang, c\u00f3 kh\u1ea3 n\u0103ng \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh tr\u01b0\u1edbc \u0111\u00e2y kh\u00f4ng th\u1ec3 d\u00f9ng thu\u1ed1c.<\/p> <p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025<\/strong>: C\u00e1c nh\u00e0 khoa h\u1ecdc c\u1ee7a Kymera ph\u00e1t hi\u1ec7n r\u1eb1ng c\u00e1c ch\u1ea5t ph\u00e2n h\u1ee7y protein c\u1ee7a h\u1ecd ho\u1ea1t \u0111\u1ed9ng r\u1ea5t ch\u00ednh x\u00e1c \u0111\u1ebfn m\u1ee9c c\u00f3 th\u1ec3 nh\u1eafm m\u1ee5c ti\u00eau t\u1eebng protein b\u1ec7nh m\u00e0 kh\u00f4ng \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn protein kh\u1ecfe m\u1ea1nh\u2014gi\u1ed1ng nh\u01b0 m\u1ed9t t\u00ean l\u1eeda th\u00f4ng minh ch\u1ec9 ph\u00e1 h\u1ee7y t\u1ebf b\u00e0o ung th\u01b0 m\u00e0 kh\u00f4ng l\u00e0m t\u1ed5n h\u1ea1i m\u00f4 b\u00ecnh th\u01b0\u1eddng!<\/p> <p>\u0110\u1ec3 c\u00f3 th\u00eam n\u1ed9i dung gi\u00e1o d\u1ee5c v\u00e0 ph\u00e2n t\u00edch th\u1ecb tr\u01b0\u1eddng, h\u00e3y truy c\u1eadp <a href=\"\/blog\">blog Pocket Option<\/a> c\u1ee7a ch\u00fang t\u00f4i, n\u01a1i ch\u00fang t\u00f4i ph\u00e2n t\u00edch c\u00e1c kh\u00e1i ni\u1ec7m \u0111\u1ea7u t\u01b0 ph\u1ee9c t\u1ea1p th\u00e0nh c\u00e1c chi\u1ebfn l\u01b0\u1ee3c \u0111\u01a1n gi\u1ea3n v\u00e0 c\u00f3 th\u1ec3 th\u1ef1c hi\u1ec7n \u0111\u01b0\u1ee3c.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Kymera: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 31 th\u00e1ng 8 n\u0103m 2025, Kymera Therapeutics (KYMR) giao d\u1ecbch \u1edf m\u1ee9c <strong>41,20 USD<\/strong> tr\u00ean NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>30 th\u00e1ng 10 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng\u2014\u0111\u00f3 l\u00e0 khi Kymera c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3. Theo l\u1ecbch s\u1eed, c\u00e1c b\u00e1o c\u00e1o n\u00e0y th\u01b0\u1eddng l\u00e0m gi\u00e1 c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh trong ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p>\n<h3><strong>C\u00e1ch B\u00e1o C\u00e1o L\u1ee3i Nhu\u1eadn \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu KYMR<\/strong><\/h3>\n<table>\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 ki\u1ec7n<\/th>\n<th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th>\n<th>Thay \u0110\u1ed5i Sau Tin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>11 th\u00e1ng 8, 2025<\/td>\n<td>L\u1ee3i nhu\u1eadn qu\u00fd 2<\/td>\n<td>42,50 USD<\/td>\n<td>-3,1% (kh\u00f4ng \u0111\u1ea1t \u01b0\u1edbc t\u00ednh)<\/td>\n<\/tr>\n<tr>\n<td>9 th\u00e1ng 5, 2025<\/td>\n<td>K\u1ebft qu\u1ea3 qu\u00fd 1<\/td>\n<td>38,20 USD<\/td>\n<td>+8,2% (ti\u1ebfn tri\u1ec3n pipeline)<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 2 n\u0103m 2025<\/td>\n<td>B\u00e1o c\u00e1o h\u00e0ng n\u0103m<\/td>\n<td>35,80 USD<\/td>\n<td>+12,3% (tin \u0111\u1ed1i t\u00e1c)<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 11 n\u0103m 2024<\/td>\n<td>C\u1eadp nh\u1eadt l\u00e2m s\u00e0ng<\/td>\n<td>32,10 USD<\/td>\n<td>+15,8% (d\u1eef li\u1ec7u t\u00edch c\u1ef1c)<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 8 n\u0103m 2024<\/td>\n<td>Qu\u00fd 2 n\u0103m 2024<\/td>\n<td>29,50 USD<\/td>\n<td>-6,2% (tr\u00ec ho\u00e3n quy \u0111\u1ecbnh)<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 5 n\u0103m 2024<\/td>\n<td>Ch\u1ec9 \u0111\u1ecbnh FDA<\/td>\n<td>26,80 USD<\/td>\n<td>+45,6% (ph\u00ea duy\u1ec7t nhanh)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Nh\u1eadn \u0111\u1ecbnh xu h\u01b0\u1edbng<\/strong>: D\u1eef li\u1ec7u l\u00e2m s\u00e0ng t\u00edch c\u1ef1c v\u00e0 c\u00e1c c\u1ed9t m\u1ed1c quy \u0111\u1ecbnh th\u01b0\u1eddng th\u00fac \u0111\u1ea9y t\u0103ng gi\u00e1 15-45%, trong khi vi\u1ec7c kh\u00f4ng \u0111\u1ea1t l\u1ee3i nhu\u1eadn g\u00e2y ra gi\u1ea3m t\u1ea1m th\u1eddi 3-6% nh\u01b0ng th\u01b0\u1eddng nhanh ch\u00f3ng h\u1ed3i ph\u1ee5c nh\u1edd tin pipeline.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u0103ng Gi\u1ea3m C\u00f3 M\u1ee5c \u0110\u00edch<\/h2>\n<p>C\u1ed5 phi\u1ebfu Kymera \u0111\u00e3 mang l\u1ea1i <strong>l\u1ee3i nhu\u1eadn 7,5%<\/strong> trong 6 th\u00e1ng qua, nh\u01b0ng h\u00e0nh tr\u00ecnh kh\u00f4ng h\u1ec1 su\u00f4n s\u1ebb:<\/p>\n<ul>\n<li><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: 35,80 USD (giai \u0111o\u1ea1n c\u1ee7ng c\u1ed1 sau k\u1ef3 ngh\u1ec9)<\/li>\n<li><strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: 42,60 USD (tin \u0111\u1ed3n h\u1ee3p t\u00e1c v\u1edbi Gilead)<\/li>\n<li><strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: 38,20 USD (giai \u0111o\u1ea1n ch\u1ed1t l\u1eddi)<\/li>\n<li><strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: 41,30 USD (l\u1ee3i nhu\u1eadn qu\u00fd 1 v\u01b0\u1ee3t k\u1ef3 v\u1ecdng)<\/li>\n<li><strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: 47,80 USD (x\u00e1c nh\u1eadn th\u1ecfa thu\u1eadn Gilead +750 tri\u1ec7u USD)<\/li>\n<li><strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: 44,20 USD (bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng)<\/li>\n<li><strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: 41,20 USD (kh\u00f4ng \u0111\u1ea1t l\u1ee3i nhu\u1eadn qu\u00fd 2)<\/li>\n<\/ul>\n<p>T\u1ea1i sao l\u1ea1i bi\u1ebfn \u0111\u1ed9ng? C\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ph\u1ee5 thu\u1ed9c r\u1ea5t nhi\u1ec1u v\u00e0o k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 tin t\u1ee9c h\u1ee3p t\u00e1c. <strong>Ph\u1ea1m vi 52 tu\u1ea7n t\u1eeb 19,45 USD \u0111\u1ebfn 53,27 USD<\/strong> cho th\u1ea5y m\u1ee9c \u0111\u1ed9 b\u00f9ng n\u1ed5 c\u1ee7a c\u1ed5 phi\u1ebfu n\u00e0y (<a href=\"https:\/\/www.macrotrends.net\/stocks\/charts\/KYMR\/kymera-therapeutics\/stock-price-history\">MacroTrends<\/a>).<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Qu\u1ef9 \u0110\u1ea1o T\u0103ng Tr\u01b0\u1edfng 2025-2030<\/h2>\n<ul>\n<li><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 52-58 USD (\u0111\u1ed9ng l\u1ef1c t\u1eeb qu\u00fd 3\/qu\u00fd 4) \u2192 <strong>MUA M\u1ea0NH<\/strong><\/li>\n<li><strong>D\u1ef1 b\u00e1o 2026<\/strong>: 65-75 USD (\u0111\u1ea1t c\u00e1c c\u1ed9t m\u1ed1c l\u00e2m s\u00e0ng)<\/li>\n<li><strong>Tri\u1ec3n v\u1ecdng 2028<\/strong>: 85-100 USD (ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i \u0111\u1ea7u ti\u00ean)<\/li>\n<li><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: 120-150 USD (v\u1ecb tr\u00ed d\u1eabn \u0111\u1ea7u th\u1ecb tr\u01b0\u1eddng)<\/li>\n<\/ul>\n<p><strong>K\u1ebft lu\u1eadn<\/strong>: \u0110\u00e2y l\u00e0 c\u1ed5 phi\u1ebfu <strong>t\u0103ng tr\u01b0\u1edfng d\u00e0i h\u1ea1n<\/strong> v\u1edbi ti\u1ec1m n\u0103ng nh\u00e2n 3-4 l\u1ea7n trong 5 n\u0103m. Nh\u00e0 \u0111\u1ea7u t\u01b0 ng\u1eafn h\u1ea1n n\u00ean ch\u00fa \u00fd k\u1ef9 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn ng\u00e0y 30 th\u00e1ng 10.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i ro c\u1ea7n c\u00e2n nh\u1eafc<\/h3>\n<ul>\n<li><strong>Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: B\u1ea5t k\u1ef3 tr\u1edf ng\u1ea1i n\u00e0o trong ch\u01b0\u01a1ng tr\u00ecnh KT-621 ho\u1eb7c KT-579 c\u00f3 th\u1ec3 khi\u1ebfn c\u1ed5 phi\u1ebfu gi\u1ea3m 30-50%<\/li>\n<li><strong>R\u00e0o c\u1ea3n quy \u0111\u1ecbnh<\/strong>: Thay \u0111\u1ed5i t\u1eeb FDA\/EMA c\u00f3 th\u1ec3 tr\u00ec ho\u00e3n ph\u00ea duy\u1ec7t v\u00e0 t\u0103ng chi ph\u00ed<\/li>\n<li><strong>Ti\u00eau ti\u1ec1n m\u1eb7t<\/strong>: Chi ti\u00eau R&#038;D qu\u00fd 78,4 tri\u1ec7u USD \u0111\u00f2i h\u1ecfi ngu\u1ed3n t\u00e0i tr\u1ee3 li\u00ean t\u1ee5c (<a href=\"https:\/\/www.ainvest.com\/news\/kymera-therapeutics-q2-2025-earnings-test-resilience-tpd-space-2508\/\">AInvest<\/a>)<\/li>\n<li><strong>C\u1ea1nh tranh<\/strong>: C\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn gia nh\u1eadp l\u0129nh v\u1ef1c TPD c\u00f3 th\u1ec3 g\u00e2y \u00e1p l\u1ef1c l\u00ean bi\u00ean l\u1ee3i nhu\u1eadn<\/li>\n<\/ul>\n<h3>T\u00edn hi\u1ec7u t\u00edch c\u1ef1c cho n\u0103m 2025<\/h3>\n<ul>\n<li><strong>Th\u1ecfa thu\u1eadn 750 tri\u1ec7u USD v\u1edbi Gilead<\/strong>: L\u00ean \u0111\u1ebfn 85 tri\u1ec7u USD tr\u1ea3 tr\u01b0\u1edbc k\u00e8m ti\u1ec1n b\u1ea3n quy\u1ec1n theo t\u1ea7ng (<a href=\"https:\/\/www.gilead.com\/news\/news-details\/2025\/gilead-sciences-and-kymera-therapeutics-enter-into-exclusive-option-and-license-agreement-to-develop-novel-oral-molecular-glue-cdk2-degraders\">Gilead Sciences<\/a>)<\/li>\n<li><strong>Ch\u1ec9 \u0111\u1ecbnh fast-track c\u1ee7a FDA<\/strong>: Ti\u1ec1n l\u1ec7 t\u0103ng gi\u00e1 c\u1ed5 phi\u1ebfu 45,58% (<a href=\"https:\/\/www.timothysykes.com\/news\/kymera-therapeutics-inc-kymr-news-2025_06_02\/\">Timothy Sykes<\/a>)<\/li>\n<li><strong>Qu\u1ef9 ti\u1ec1n m\u1eb7t 1 t\u1ef7 USD<\/strong>: \u0110\u1ea3m b\u1ea3o t\u00e0i tr\u1ee3 \u0111\u1ebfn n\u0103m 2028<\/li>\n<li><strong>20 nh\u00e0 ph\u00e2n t\u00edch \u0111\u00e1nh gi\u00e1 &#8220;Mua&#8221;<\/strong>: Ni\u1ec1m tin chuy\u00ean nghi\u1ec7p \u0111\u1ed3ng thu\u1eadn<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Ch\u1ec9 ph\u00e2n b\u1ed5 2-5% danh m\u1ee5c cho c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li>\n<li><strong>Trung b\u00ecnh gi\u00e1 theo th\u1eddi gian<\/strong>: Mua 100-200 USD m\u1ed7i tu\u1ea7n \u0111\u1ec3 tr\u00e1nh sai l\u1ea7m v\u1ec1 th\u1eddi \u0111i\u1ec3m<\/li>\n<li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/strong>: Mua khi gi\u00e1 gi\u1ea3m d\u01b0\u1edbi 40 USD, ch\u1ed1t l\u1eddi tr\u00ean 50 USD<\/li>\n<li><strong>\u0110a d\u1ea1ng h\u00f3a<\/strong>: C\u00e2n b\u1eb1ng v\u1edbi c\u1ed5 phi\u1ebfu tr\u1ea3 c\u1ed5 t\u1ee9c \u1ed5n \u0111\u1ecbnh<\/li>\n<li><strong>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc<\/strong>: &#8220;Giao d\u1ecbch KYMR gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba\u2014\u0111\u1ea7y nh\u1eefng \u0111\u1ed9t ph\u00e1 th\u00fa v\u1ecb k\u00e8m theo v\u00e0i v\u1ee5 n\u1ed5 ph\u00f2ng th\u00ed nghi\u1ec7m. H\u00e3y lu\u00f4n \u0111eo k\u00ednh b\u1ea3o h\u1ed9!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Kymera Therapeutics (KYMR) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o truy c\u1eadp NASDAQ v\u00e0 ph\u00ed th\u1ea5p<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>M\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi 500-1000 USD \u0111\u1ec3 \u0111\u1ecbnh k\u00edch th\u01b0\u1edbc v\u1ecb th\u1ebf<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;KYMR&#8221;<\/td>\n<td>D\u00f9ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng d\u00f9ng t\u00ean c\u00f4ng ty<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td>\n<td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td>\n<td>Ki\u1ec3m tra t\u1ef7 l\u1ec7 hoa h\u1ed3ng (d\u01b0\u1edbi 1% l\u00e0 l\u00fd t\u01b0\u1edfng)<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Gi\u00e1m s\u00e1t v\u1ecb th\u1ebf<\/td>\n<td>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7 \u1edf m\u1ee9c 15-20% d\u01b0\u1edbi gi\u00e1 v\u00e0o<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>T\u00e1i \u0111\u1ea7u t\u01b0 c\u1ed5 t\u1ee9c<\/td>\n<td>KYMR ch\u01b0a tr\u1ea3 c\u1ed5 t\u1ee9c\u2014t\u1eadp trung v\u00e0o t\u0103ng tr\u01b0\u1edfng<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Theo d\u00f5i tin t\u1ee9c<\/td>\n<td>\u0110\u0103ng k\u00fd nh\u1eadn c\u1ea3nh b\u00e1o tin t\u1ee9c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>\u0110\u00e1nh gi\u00e1 h\u00e0ng qu\u00fd<\/td>\n<td>\u0110\u00e1nh gi\u00e1 l\u1ea1i sau m\u1ed7i b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Xem x\u00e9t t\u00e1c \u0111\u1ed9ng thu\u1ebf<\/td>\n<td>Gi\u1eef tr\u00ean 1 n\u0103m \u0111\u1ec3 \u0111\u01b0\u1ee3c \u01b0u \u0111\u00e3i thu\u1ebf l\u1ee3i t\u1ee9c v\u1ed1n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>Pocket Option gi\u00fap \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc tr\u1edf n\u00ean d\u1ec5 ti\u1ebfp c\u1eadn cho m\u1ecdi ng\u01b0\u1eddi:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u: 5 USD<\/strong> \u2014 Th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro th\u1ea5p<\/li>\n<li><strong>X\u00e1c minh trong 1 ph\u00fat<\/strong> \u2014 KYC ch\u1ec9 v\u1edbi m\u1ed9t t\u00e0i li\u1ec7u gi\u00fap b\u1ea1n giao d\u1ecbch ngay l\u1eadp t\u1ee9c<\/li>\n<li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> \u2014 Bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed, chuy\u1ec3n kho\u1ea3n ng\u00e2n h\u00e0ng<\/li>\n<li><strong>C\u1ed5 phi\u1ebfu ph\u00e2n \u0111o\u1ea1n<\/strong> \u2014 Mua c\u1ed5 phi\u1ebfu m\u1ed9t ph\u1ea7n c\u1ee7a c\u00e1c c\u1ed5 phi\u1ebfu \u0111\u1eaft ti\u1ec1n nh\u01b0 KYMR<\/li>\n<\/ul>\n<h2>\ud83c\udf0d Kymera N\u0103m 2025: Ng\u01b0\u1eddi Ti\u00ean Phong Ph\u00e2n H\u1ee7y Protein<\/h2>\n<p>Kymera Therapeutics kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u00f4ng th\u01b0\u1eddng\u2014h\u1ecd \u0111ang d\u1eabn \u0111\u1ea7u cu\u1ed9c c\u00e1ch m\u1ea1ng ph\u00e2n h\u1ee7y protein c\u00f3 m\u1ee5c ti\u00eau. C\u00f4ng ngh\u1ec7 c\u1ee7a c\u00f4ng ty s\u1eed d\u1ee5ng &#8220;keo ph\u00e2n t\u1eed&#8221; \u0111\u1ec3 lo\u1ea1i b\u1ecf c\u00e1c protein g\u00e2y b\u1ec7nh thay v\u00ec ch\u1ec9 ch\u1eb7n ch\u00fang, c\u00f3 kh\u1ea3 n\u0103ng \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh tr\u01b0\u1edbc \u0111\u00e2y kh\u00f4ng th\u1ec3 d\u00f9ng thu\u1ed1c.<\/p>\n<p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025<\/strong>: C\u00e1c nh\u00e0 khoa h\u1ecdc c\u1ee7a Kymera ph\u00e1t hi\u1ec7n r\u1eb1ng c\u00e1c ch\u1ea5t ph\u00e2n h\u1ee7y protein c\u1ee7a h\u1ecd ho\u1ea1t \u0111\u1ed9ng r\u1ea5t ch\u00ednh x\u00e1c \u0111\u1ebfn m\u1ee9c c\u00f3 th\u1ec3 nh\u1eafm m\u1ee5c ti\u00eau t\u1eebng protein b\u1ec7nh m\u00e0 kh\u00f4ng \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn protein kh\u1ecfe m\u1ea1nh\u2014gi\u1ed1ng nh\u01b0 m\u1ed9t t\u00ean l\u1eeda th\u00f4ng minh ch\u1ec9 ph\u00e1 h\u1ee7y t\u1ebf b\u00e0o ung th\u01b0 m\u00e0 kh\u00f4ng l\u00e0m t\u1ed5n h\u1ea1i m\u00f4 b\u00ecnh th\u01b0\u1eddng!<\/p>\n<p>\u0110\u1ec3 c\u00f3 th\u00eam n\u1ed9i dung gi\u00e1o d\u1ee5c v\u00e0 ph\u00e2n t\u00edch th\u1ecb tr\u01b0\u1eddng, h\u00e3y truy c\u1eadp <a href=\"\/blog\">blog Pocket Option<\/a> c\u1ee7a ch\u00fang t\u00f4i, n\u01a1i ch\u00fang t\u00f4i ph\u00e2n t\u00edch c\u00e1c kh\u00e1i ni\u1ec7m \u0111\u1ea7u t\u01b0 ph\u1ee9c t\u1ea1p th\u00e0nh c\u00e1c chi\u1ebfn l\u01b0\u1ee3c \u0111\u01a1n gi\u1ea3n v\u00e0 c\u00f3 th\u1ec3 th\u1ef1c hi\u1ec7n \u0111\u01b0\u1ee3c.<\/p>\n"},"faq":[{"question":"Kymera Therapeutics l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Kymera Therapeutics l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean phong trong c\u00f4ng ngh\u1ec7 ph\u00e2n h\u1ee7y protein c\u00f3 m\u1ee5c ti\u00eau, nh\u1eb1m ph\u00e1t tri\u1ec3n c\u00e1c li\u1ec7u ph\u00e1p \u0111i\u1ec1u tr\u1ecb b\u1ec7nh m\u1edbi b\u1eb1ng c\u00e1ch lo\u1ea1i b\u1ecf c\u00e1c protein g\u00e2y b\u1ec7nh."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu KYMR?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu KYMR th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n c\u00f3 truy c\u1eadp NASDAQ, b\u1eb1ng c\u00e1ch t\u00ecm m\u00e3 ch\u1ee9ng kho\u00e1n \"KYMR\", ch\u1ecdn lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a m\u00ecnh."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o KYMR l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, r\u00e0o c\u1ea3n quy \u0111\u1ecbnh, chi ti\u00eau ti\u1ec1n m\u1eb7t l\u1edbn v\u00e0 c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn kh\u00e1c."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a KYMR trong t\u01b0\u01a1ng lai ra sao?","answer":"KYMR \u0111\u01b0\u1ee3c d\u1ef1 b\u00e1o c\u00f3 ti\u1ec1m n\u0103ng t\u0103ng gi\u00e1 3-4 l\u1ea7n trong 5 n\u0103m t\u1edbi, v\u1edbi c\u00e1c m\u1ed1c quan tr\u1ecdng nh\u01b0 \u0111\u1ea1t c\u1ed9t m\u1ed1c l\u00e2m s\u00e0ng, ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i v\u00e0 v\u1ecb tr\u00ed d\u1eabn \u0111\u1ea7u th\u1ecb tr\u01b0\u1eddng."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 KYMR?","answer":"Pocket Option cung c\u1ea5p n\u1ec1n t\u1ea3ng d\u1ec5 s\u1eed d\u1ee5ng v\u1edbi s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 cho ph\u00e9p mua c\u1ed5 phi\u1ebfu ph\u00e2n \u0111o\u1ea1n, ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Kymera Therapeutics l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Kymera Therapeutics l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean phong trong c\u00f4ng ngh\u1ec7 ph\u00e2n h\u1ee7y protein c\u00f3 m\u1ee5c ti\u00eau, nh\u1eb1m ph\u00e1t tri\u1ec3n c\u00e1c li\u1ec7u ph\u00e1p \u0111i\u1ec1u tr\u1ecb b\u1ec7nh m\u1edbi b\u1eb1ng c\u00e1ch lo\u1ea1i b\u1ecf c\u00e1c protein g\u00e2y b\u1ec7nh."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu KYMR?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu KYMR th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n c\u00f3 truy c\u1eadp NASDAQ, b\u1eb1ng c\u00e1ch t\u00ecm m\u00e3 ch\u1ee9ng kho\u00e1n \"KYMR\", ch\u1ecdn lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a m\u00ecnh."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o KYMR l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, r\u00e0o c\u1ea3n quy \u0111\u1ecbnh, chi ti\u00eau ti\u1ec1n m\u1eb7t l\u1edbn v\u00e0 c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn kh\u00e1c."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a KYMR trong t\u01b0\u01a1ng lai ra sao?","answer":"KYMR \u0111\u01b0\u1ee3c d\u1ef1 b\u00e1o c\u00f3 ti\u1ec1m n\u0103ng t\u0103ng gi\u00e1 3-4 l\u1ea7n trong 5 n\u0103m t\u1edbi, v\u1edbi c\u00e1c m\u1ed1c quan tr\u1ecdng nh\u01b0 \u0111\u1ea1t c\u1ed9t m\u1ed1c l\u00e2m s\u00e0ng, ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i v\u00e0 v\u1ecb tr\u00ed d\u1eabn \u0111\u1ea7u th\u1ecb tr\u01b0\u1eddng."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 KYMR?","answer":"Pocket Option cung c\u1ea5p n\u1ec1n t\u1ea3ng d\u1ec5 s\u1eed d\u1ee5ng v\u1edbi s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 cho ph\u00e9p mua c\u1ed5 phi\u1ebfu ph\u00e2n \u0111o\u1ea1n, ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-31T12:50:20+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR)\",\"datePublished\":\"2025-08-31T12:50:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"datePublished\":\"2025-08-31T12:50:20+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-31T12:50:20+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR)","datePublished":"2025-08-31T12:50:20+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","datePublished":"2025-08-31T12:50:20+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":364721,"slug":"how-to-buy-kymera-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Kymera Therapeutics, Inc. (KYMR) - Investimento em a\u00e7\u00f5es da Kymera Therapeutics, Inc. (KYMR)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/364717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=364717"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/364717\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334009"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=364717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=364717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=364717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}